Belviq Cancer Risk and Lawsuits Over Recalled Diet Drug
It has been more than 18 months since federal regulators recalled Belviq due to a cancer risk associated with the diet drug. However, as new cases of Belvic cancer continue to emerge and individuals learn that previously diagnosed cancer may have resulted from side effects of… Read More
Injectafer FDA Label Warnings About Hypophosphatemia (HPP) Risks Remain Inadequate
The Injectafer FDA label was updated in February 2020 with new information about severe hypophosphatemia (HPP) risks. However, these warnings remain insufficient and continue to provide misleading information, which fails to fully describe the serious and potentially life-threatening nature of Injectafer side effects that may be… Read More
Multimodal Imaging Can Help Diagnose Elmiron Eye Damage Known as Pigmentary Maculopathy
As our lawyers at Saiontz & Kirk, P.A. continue to investigate and review Elmiron lawsuits for individuals left with a form of vision damage known as pigmentary maculopathy, it is important for former long-term users of the bladder drug to be aware that a relatively simple… Read More
Elmiron Class Action Lawsuit vs. Multidistrict Litigation (MDL) for Individual Injury Claims
With a growing number of lawsuits being pursued nationwide by former users of Elmiron diagnosed with retina damage known as pigmentary maculopathy, a panel of federal judges recently established consolidated pretrial proceedings for the claims, known as a multidistrict litigation (MDL). While this process is often… Read More
Elmiron Eye Problems May Have Been Avoided If Earlier Warnings About Maculopathy and Macular Degeneration Had Been Provided
In recent years, there have been a growing number of independent studies and case reports that highlight the link between Elmiron and eye problems, leading to lawsuits brought on behalf of former users of the bladder drug who have been left with maculopathy, macular degeneration and… Read More
Elmiron Vision Side Effects May Cause Pigmentary Maculopathy
The product liability lawyers at Saiontz & Kirk, P.A. are now investigating potential lawsuits for users of the interstitial cytisis/bladder pain syndrome drug Elmiron, which may have caused a type of retina damage and vision loss known as pigmentary maculopathy. [form id='59' title='Contact Our Elmiron Lawyers… Read More
Zantac, Zantac OTC and Ranitidine Recall Issued Due to NDMA Contamination
Following months of concerns about whether side effects of ranitidine in Zantac increase the risk of cancer, the U.S. Food and Drug Administration (FDA) announced today that all ranitidine-based drugs should be removed from the market, including name-brand Zantac, over-the-counter and all generic equivalents. (more…) Read More
Belviq Recall Lawyers Investigating Weight Loss Drug Cancer Claims
On February 13, the U.S. Food and Drug Administration announced that a Belviq recall should be issued to remove the popular weight loss drug from the market, after post-marketing clinical trials identified a cancer risk for users. [form id='7' title='Contact Our Belviq Lawyers To REVIEW A… Read More
HIV Drug Side Effects May Have Been Avoided With Safer Tenofovir Versions
The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential claims for individuals who suffered side effects from HIV drugs that are part of a class of medications known as tenofovir disoproxil fumarate (TDF), which includes the medications Truvada, Atripla, Stribild, Complera and Viread.… Read More